715213000: Irinotecan liposome (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Topoisomerase inhibitor\Irinotecan liposome (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\...

\Carbamic acid (substance)\Irinotecan liposome (substance)

\Pyridine and/or pyridine derivative\Piperidine\Irinotecan liposome (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Pyridine and/or pyridine derivative\Piperidine\Irinotecan liposome (substance)
\Organic compound\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic ester (substance)\Irinotecan liposome (substance)
\Organic compound\Organic acid and/or organic acid derivative\Carboxylic acid and/or carboxylic acid derivative (substance)\Carboxylic acid\Carbamate (substance)\Carbamic acid (substance)\Irinotecan liposome (substance)
\Organic compound\Organic nitrogen compound\Carbamic acid (substance)\Irinotecan liposome (substance)
\Organic compound\Organic nitrogen compound\Pyridine and/or pyridine derivative\Piperidine\Irinotecan liposome (substance)
\Organic compound\Lipid\Phospholipid\Liposomal agent (substance)\Irinotecan liposome (substance)
\Organic compound\Ester\Carboxylic ester (substance)\Irinotecan liposome (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3301881016 Irinotecan liposome (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3301882011 Irinotecan liposome en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Irinotecan liposome (substance)	Is a	Irinotecan (substance)	false	Inferred relationship	Some
Irinotecan liposome (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Topoisomerase inhibitor (disposition)	true	Inferred relationship	Some
Irinotecan liposome (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Irinotecan (substance)	true	Inferred relationship	Some
Irinotecan liposome (substance)	Is a	Liposomal agent (substance)	true	Inferred relationship	Some
Irinotecan liposome (substance)	Is a	Topoisomerase inhibitor	true	Inferred relationship	Some
Irinotecan liposome (substance)	Is a	Carbamic acid (substance)	true	Inferred relationship	Some
Irinotecan liposome (substance)	Is a	Piperidine	true	Inferred relationship	Some
Irinotecan liposome (substance)	Is a	Carboxylic ester (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Irinotecan liposome only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irinotecan liposome (substance)	Inferred relationship	Some	1
Irinotecan liposome only product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Irinotecan liposome (substance)	Inferred relationship	Some	1

This concept is not in any reference sets